Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

J Allergy Clin Immunol Pract. 2020 Feb;8(2):799-802. doi: 10.1016/j.jaip.2019.08.011. Epub 2019 Aug 19.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioedemas, Hereditary* / drug therapy
  • Angioedemas, Hereditary* / prevention & control
  • Complement C1 Inactivator Proteins
  • Complement C1 Inhibitor Protein* / therapeutic use
  • Esterases
  • Humans
  • Recombinant Proteins

Substances

  • Complement C1 Inactivator Proteins
  • Complement C1 Inhibitor Protein
  • Recombinant Proteins
  • Esterases